Teenagers are increasingly being warned about a social-media-driven “heightmaxxing” trend in which some people take the cancer drug erdafitinib in hopes of growing taller. Multiple outlets say the drug is being promoted in online forums and videos, with claims that it can add inches, including posts encouraging others to seek sourcing and dosage information.

Several reports focus on how the trend is framed online, including references to the drug being discussed on biohacking and self-improvement communities and TikTok content that urges followers to act quickly. One account described a teenager using the medication intermittently for a period of time, while other examples mention motivations tied to appearance and confidence.

Medical and general-interest coverage also stresses the risks. Outlets describe reports of side effects among users, including joint pain, nosebleeds, severe dry skin, and other adverse effects. Overall, the sources agree that erdafitinib’s use for height lacks appropriate medical oversight and can be harmful, while differing mainly in how they emphasize the online promotion versus the clinical warning context.